UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060847
Receipt number R000069626
Scientific Title An exploratory Study on the Effects of Fatigue on Cognitive Function (SWE-2026-02-HBPUFA)
Date of disclosure of the study information 2026/03/08
Last modified on 2026/03/06 13:49:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory Study on the Effects of Fatigue on Cognitive Function
(SWE-2026-02-HBPUFA)

Acronym

An exploratory Study on the Effects of Fatigue on Cognitive Function

Scientific Title

An exploratory Study on the Effects of Fatigue on Cognitive Function
(SWE-2026-02-HBPUFA)

Scientific Title:Acronym

An exploratory Study on the Effects of Fatigue on Cognitive Function

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of fatigue on cognitive function.

Basic objectives2

Others

Basic objectives -Others

To evaluate the effects of fatigue on cognitive function.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cognitive function

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Information updating task

Interventions/Control_2

Dynamic information processing task

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

54 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Males and females aged 40 to 54 years
(2) Individuals who have fully understood the purpose and content of the study and have provided written informed consent

Key exclusion criteria

(1) Individuals deemed to have difficulty in performing cognitive function tests
(2) Individuals with injuries or medical conditions that interfere with the operation of electronic devices such as computers
(3) Individuals using pharmaceuticals, foods for specified health uses, foods with function claims, or health foods that may affect the study
(4) Individuals with a current or past history of serious diseases such as neurological disorders, psychiatric disorders, liver disorders, kidney disorders, respiratory disorders, cardiovascular disorders, diabetes mellitus, or food allergies
(5) Individuals judged by the principal investigator to be otherwise inappropriate as study participants

Target sample size

39


Research contact person

Name of lead principal investigator

1st name Hisanori
Middle name
Last name Tokuda

Organization

Suntory Wellness Limited

Division name

Institute for Science of Life

Zip code

619-0238

Address

8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto. 619-0284, Japan.

TEL

050-1804-0275

Email

Hisanori_Tokuda@suntory.co.jp


Public contact

Name of contact person

1st name Masataka
Middle name
Last name Mizunuma

Organization

Suntory Wellness Limited

Division name

Institute for Science of Life

Zip code

619-0238

Address

8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto. 619-0284, Japan.

TEL

050-1739-0301

Homepage URL


Email

Masataka_Mizunuma@suntory.co.jp


Sponsor or person

Institute

Suntory Wellness Limited

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation DiaStep, Ouchi no Doctor Clinical Research Ethics Review Committee

Address

4F Ryobi Building, 3-33-13 Mukojima, Sumida-ku, Tokyo 131-0033, Japan

Tel

03-5809-7660

Email

tomohisa.kato@diastep.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 03 Month 06 Day

Date of IRB


Anticipated trial start date

2026 Year 03 Month 09 Day

Last follow-up date

2026 Year 04 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 03 Month 06 Day

Last modified on

2026 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069626